A Randomised ,double blind,triple-dummy 6 way crossover ,single center study to evaluate the oral abuse potential of intact and chewed oxycodone DETERx capsules with crushed immediate -release oxycodone

Trial Profile

A Randomised ,double blind,triple-dummy 6 way crossover ,single center study to evaluate the oral abuse potential of intact and chewed oxycodone DETERx capsules with crushed immediate -release oxycodone

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2017 Primary endpoint (Peak "Drug Liking" (Emax) when compared with crushed immediate-release oxycodone) has been met, according to a Colligium Pharmaceutical media release.
    • 01 Feb 2017 Results published in a Collegium Pharmaceutical media release.
    • 04 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top